UK markets close in 1 hour 39 minutes

Apyx Medical Corporation (APYX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.3100-0.0100 (-0.76%)
As of 09:30AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
48,723
52,349
44,510
48,517
27,711
Cost of revenue
15,682
18,590
15,379
14,916
10,207
Gross profit
33,041
33,759
29,131
33,601
17,504
Operating expenses
Research development
4,236
4,844
4,544
4,321
3,920
Selling general and administrative
48,126
48,866
48,149
43,728
33,667
Total operating expenses
52,362
53,710
52,693
48,049
37,587
Operating income or loss
-19,321
-19,951
-23,562
-14,448
-20,083
Interest expense
13
2,478
15
10
46
Total other income/expenses net
366
226
509
-373
479
Income before tax
-18,873
-21,282
-22,911
-14,820
-19,409
Income tax expense
350
-2,432
367
380
-7,503
Income from continuing operations
-19,223
-18,850
-23,278
-15,200
-11,906
Net income
-19,138
-18,713
-23,184
-15,172
-11,896
Net income available to common shareholders
-19,138
-18,713
-23,184
-15,172
-11,896
Basic EPS
-0.43
-0.54
-0.67
-0.44
-0.35
Diluted EPS
-0.43
-0.54
-0.67
-0.44
-0.35
Basic average shares
34,611
34,622
34,516
34,332
34,212
Diluted average shares
34,611
34,622
34,516
34,332
34,212